Artificial intelligence has aided in the advancement of healthcare research. The availability
of open-source healthcare statistics has prompted researchers to create applications that aid …

Cancer remains one of the deadliest diseases, and its effective diagnosis and treatment
remains challenging; therefore, progress in earlier detection and improved therapeutics are …

Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of
the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is …

Thyroid disease is the general concept for a medical problem that prevents one's thyroid
from producing enough hormones. Thyroid disease can affect everyone—men, women …

Background Treatment options for advanced thyroid cancer refractory to standard therapies
are limited. The safety and efficacy of pembrolizumab were evaluated in patients with …

Increasing evidence has indicated a close association between immune infiltration in cancer
and clinical outcomes. However, related research in thyroid cancer is still deficient. Our …

Intranasal (IN) delivery is a rapidly developing area for therapies with great potential for the
treatment of central nervous system (CNS) diseases. Moreover, in vivo imaging is becoming …

Background and objective In the healthcare context, healthcare personnel are available to
help patients according to their requirements. However, having sufficient knowledge of many …

Thyroid cancer is the most common endocrine malignancy. Most thyroid cancer types
respond well to conventional treatment consisting of surgery and radioactive iodine (RAI) …

M2‑like tumour‑associated macrophages (TAMs) have been demonstrated to promote the
growth of anaplastic thyroid carcinoma (ATC). However, the underlying mechanism of M2 …